NEW YORK, Sept. 22, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:
Rosetta Stone Inc. (NYSE: RST)
A solicitation statement was recently filed with the SEC regarding Cambium Learning Group's acquisition of Rosetta Stone, which may omit material information regarding the financial metrics and analyses used to evaluate the merger. Under the proposed transaction, shareholders of Rosetta Stone will receive $30.00 for every share owned.
Akcea Therapeutics, Inc. (NASDAQ: AKCA)
Akcea has agreed to be acquired by Ionis. Under the proposed transaction, shareholders of Akcea will receive $18.15 for each share owned.
Dime Community Bancshares, Inc. (NASDAQ: DCOM)
A registration statement was recently filed with the SEC regarding Bridge Bancorp's acquisition of Dime. Upon completion of the merger, shareholders of Dime will receive 0.6480 shares of Bridge Bancorp for every share owned. The investigation concerns whether Dime's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.
Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)
A registration statement was recently filed with the SEC regarding F-star Therapeutics' acquisition of Spring Bank. Upon completion of the merger, shareholders of Spring Bank will only own approximately 38.8% of the combined company.
Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at email@example.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star New York City-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-encourages-rst-akca-dcom-and-sbph-investors-to-contact-law-firm-301135977.html
SOURCE Moore Kuehn, PLLC
Get the Latest AKCA - Akcea Therapeutics, Inc. News & Updates!